Neuroscience
Parkinson's Disease
100%
Oxidopamine
37%
Metabotropic Glutamate Receptor
34%
Reserpine
28%
Akinesia
27%
Agonist
27%
Neuroprotection
26%
Dyskinesia
26%
L-DOPA
25%
Substantia nigra
25%
Receptor Agonists
23%
Glutamic Acid
22%
Pars reticulata
21%
Neuroprotective Agent
20%
Basal Ganglia
19%
Dopaminergic
16%
Eicosanoid Receptor
16%
Neuron
15%
Striatum
15%
Gamma-Aminobutyric Acid
13%
In Vivo
13%
Brain
12%
Dopamine
12%
Nicotine
11%
4 Aminobutyric Acid B Receptor
11%
Riluzole
11%
Fibroblast Growth Factor
11%
Tyrosine Hydroxylase
11%
In Vitro
11%
Substantia Nigra Pars Compacta
11%
Globus pallidus
11%
Ligand
9%
Treatment of Parkinson's Disease
8%
Nicotinic Acetylcholine Receptor
7%
Astrocyte
7%
Tetrahydropyridine
7%
Forebrain
7%
Nigrostriatal Pathway
7%
Neurodegeneration
7%
Heteroreceptor
7%
Serine
7%
Gene Expression
6%
Suppression
6%
Cell Loss
6%
Glutamate Receptor
5%
N Acetylgalactosamine 4 Sulfatase
5%
Antibodies
5%
DCG-IV
5%
Alpha-7 Nicotinic Receptor
5%
Zolpidem
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson Disease
60%
Metabotropic Receptor
37%
Rat
26%
Diseases
22%
Reserpine
19%
Receptor
18%
Akinesia
18%
Glutamic Acid
17%
Agonist
14%
Drug
14%
Oxidopamine
14%
Symptom
14%
Rodent
13%
Dopamine Receptor Stimulating Agent
13%
4 Aminobutyric Acid
11%
Rat Model
10%
Neuroprotective Agent
8%
Pathogenesis
8%
Ligand
7%
Antiparkinson Agent
7%
Animal
7%
Nerve Degeneration
7%
Serine
7%
Growth Factor
6%
Receptor Agonist
6%
Enalapril Maleate
6%
Mouse Model
6%
Glutamate Receptor
5%
Motor Dysfunction
5%
Neuroprotection
5%
CD71 Antigen
5%
Nicotinic Receptor
5%
Antibody
5%
Receptor Subtype
5%
Nicotine
5%
Phosphate
5%
Imidazoline
5%
Monoamine Oxidase Inhibitor
5%
Pain
5%
Levodopa-Induced Dyskinesia
5%
Medicine and Dentistry
Parkinson's Disease
32%
Lesion
21%
Dopamine Agonist
18%
Metabotropic Receptor
17%
Globus pallidus
17%
Therapeutic Procedure
14%
Oxidopamine
14%
Chemotherapeutic Agent
13%
Drug
13%
Fibroblast Growth Factor
11%
Substantia Nigra Pars Reticulata
9%
Receptor
8%
Neuroprotection
7%
Levodopa-Induced Dyskinesia
6%
Pathogenesis
6%
Gamma-Aminobutyric Acid
6%
Cell Loss
6%
Reserpine
6%
Neuron
5%
Enalapril Maleate
5%
Basal Ganglia
5%
Brain
5%
Riluzole
5%
Neuroimaging
5%
Flumazenil
5%
Zolpidem
5%
Morphometrics
5%
Programmed Cell Death
5%
4 Aminobutyric Acid B Receptor
5%
Disease Model
5%
Astrocytosis
5%
N Acetylgalactosamine 4 Sulfatase
5%
Regulatory Mechanism
5%
Akinesia
5%
Phosphate
5%
Messenger RNA
5%
Serine
5%
Symptom
5%